Please assess the completion status of the following clinical trial:

Trial Title: Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Moderate-severe COPD (Global inititiative for chronic Obstructive Lung Disease, GOLD, 2003 definition)~* Smoking history of at least 10 pack-years~Exclusion Criteria:~* Any significant co-morbid disease~* Use of any maintenance therapy except short acting bronchodilators

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).